BLUE-181

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameBLUE-181
Drug Alias NameBLUE-181
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors modulators
TargetsOpioid receptors
Therapy Area/IndicationsAnxiety DisordersPainIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlue Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlue Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAnxiety DisordersPainIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A